The DOI matches its Crossref record; 112 of the 112 references it cites were found in a registry or an index.
Adoptive T cell therapy for cancer in the clinic
Open accessAbstract
The transfusion of lymphocytes, referred to as adoptive T cell therapy, is being tested for the treatment of cancer and chronic infections.Adoptive T cell therapy has the potential to enhance antitumor immunity, augment vaccine efficacy, and limit graft-versus-host disease.This form of personalized medicine is now in various early-and late-stage clinical trials.These trials are currently testing strategies to infuse tumor-infiltrating lymphocytes, CTLs, Th cells, and Tregs.Improved molecular biology techniques have also increased enthusiasm and feasibility for testing genetically engineered T cells.The current status of the field and prospects for clinical translation are reviewed herein.Nonstandard abbreviations used: DLI, donor lymphocyte infusion; GVHD, graftversus-host disease; HSV-TK, herpes simplex virus thymidine kinase; MART-1, melanoma-associated antigen recognized by T cells 1; TIL, tumor-infiltrating lymphocyte.Conflict of interest: C.H. June receives income from BD Biosciences, Cell Genesys, CellDex Therapeutics, Maxcyte, and AVEO Pharmaceuticals Inc. and research sup-
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
New Guidelines to Evaluate the Response to Treatment in Solid Tumors
Therasse, P., Arbuck, S. G., Eisenhauer, E. A., Wanders, J., Kaplan, R. S., Rubinstein, L., Verweij, J., Van Glabbeke, M., van Oosterom, A. T., Christian, M. C., et al. (2000) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/92.3.205 · Cited by 15,660
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
Galon, J., Costes, A., Sanchez-Cabo, F., Kirilovsky, A., Mlecnik, B., Lagorce-Pagès, C., Tosolini, M., Camus, M., Berger, A., Wind, P., et al. (2006) · Science · doi:10.1126/science.1129139 · Cited by 6,516
Restoring function in exhausted CD8 T cells during chronic viral infection
Barber, D. L., Wherry, E. J., Masopust, D., Zhu, B., Allison, J. P., Sharpe, A. H., Freeman, G. J., & Ahmed, R. (2006) · Nature · doi:10.1038/nature04444 · Cited by 3,986
LMO2 -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
Hacein-Bey-Abina, S., Von Kalle, C., Schmidt, M., McCormack, M. P., Wulffraat, N., Leboulch, P., Lim, A., Osborne, C. S., Pawliuk, R., Morillon, E., et al. (2003) · Science · doi:10.1126/science.1088547 · Cited by 3,587
A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma
van der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C., De Plaen, E., Van den Eynde, B., Knuth, A., & Boon, T. (1991) · Science · doi:10.1126/science.1840703 · Cited by 3,545
Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer
Zhang, L., Conejo-Garcia, J. R., Katsaros, D., Gimotty, P. A., Massobrio, M., Regnani, G., Makrigiannakis, A., Gray, H., Schlienger, K., Liebman, M. N., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020177 · Cited by 3,397
Calreticulin exposure dictates the immunogenicity of cancer cell death
Obeid, M., Tesniere, A., Ghiringhelli, F., Fimia, G. M., Apetoh, L., Perfettini, J.-L., Castedo, M., Mignot, G., Panaretakis, T., Casares, N., et al. (2007) · Nature Medicine · doi:10.1038/nm1523 · Cited by 3,216
The Consensus Coding Sequences of Human Breast and Colorectal Cancers
Sjöblom, T., Jones, S., Wood, L. D., Parsons, D. W., Lin, J., Barber, T. D., Mandelker, D., Leary, R. J., Ptak, J., Silliman, N., et al. (2006) · Science · doi:10.1126/science.1133427 · Cited by 3,169
Cancer immunotherapy: moving beyond current vaccines
Rosenberg, S. A., Yang, J. C., & Restifo, N. P. (2004) · Nature Medicine · doi:10.1038/nm1100 · Cited by 2,972
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
Shankaran, V., Ikeda, H., Bruce, A. T., White, J. M., Swanson, P. E., Old, L. J., & Schreiber, R. D. (2001) · Nature · doi:10.1038/35074122 · Cited by 2,896
Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes
Dudley, M. E., Wunderlich, J. R., Robbins, P. F., Yang, J. C., Hwu, P., Schwartzentruber, D. J., Topalian, S. L., Sherry, R., Restifo, N. P., Hubicki, A. M., et al. (2002) · Science · doi:10.1126/science.1076514 · Cited by 2,823
Cancer regression in patients after transfer of genetically engineered lymphocytes
Morgan, R. A., Dudley, M. E., Wunderlich, J. R., Hughes, M. S., Yang, J. C., Sherry, R. M., Royal, R. E., Topalian, S. L., Kammula, U. S., Restifo, N. P., et al. (2006) · Science · doi:10.1126/science.1129003 · Cited by 2,603
Sato, E., Olson, S. H., Ahn, J., Bundy, B., Nishikawa, H., Qian, F., Jungbluth, A. A., Frosina, D., Gnjatic, S., Ambrosone, C., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509182102 · Cited by 2,372
Effector Memory T Cells, Early Metastasis, and Survival in Colorectal Cancer
Pagès, F., Berger, A., Camus, M., Sanchez-Cabo, F., Costes, A., Molidor, R., Mlecnik, B., Kirilovsky, A., Nilsson, M., Damotte, D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051424 · Cited by 2,135
Dudley, M. E., Wunderlich, J. R., Yang, J. C., Sherry, R. M., Topalian, S. L., Restifo, N. P., Royal, R. E., Kammula, U., White, D. E., Mavroukakis, S. A., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.00.240 · Cited by 1,639
T Lymphocyte-Directed Gene Therapy for ADA − SCID: Initial Trial Results After 4 Years
Blaese, R. M., Culver, K. W., Miller, A. D., Carter, C. S., Fleisher, T., Clerici, M., Shearer, G., Chang, L., Chiang, Y., Tolstoshev, P., et al. (1995) · Science · doi:10.1126/science.270.5235.475 · Cited by 1,550
Edinger, M., Hoffmann, P., Ermann, J., Drago, K., Fathman, C. G., Strober, S., & Negrin, R. S. (2003) · Nature Medicine · doi:10.1038/nm915 · Cited by 1,288
A Phase I Study on Adoptive Immunotherapy Using Gene-Modified T Cells for Ovarian Cancer
Kershaw, M. H., Westwood, J. A., Parker, L. L., Wang, G., Eshhar, Z., Mavroukakis, S. A., White, D. E., Wunderlich, J. R., Canevari, S., Rogers-Freezer, L., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1183 · Cited by 1,254
Yee, C., Thompson, J. A., Byrd, D., Riddell, S. R., Roche, P., Celis, E., & Greenberg, P. D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242600099 · Cited by 1,206
Marincola, F. M., Jaffee, E. M., Hicklin, D. J., & Ferrone, S. (1999) · Advances in Immunology · doi:10.1016/s0065-2776(08)60911-6 · Cited by 1,174
HSV-TK Gene Transfer into Donor Lymphocytes for Control of Allogeneic Graft-Versus-Leukemia
Bonini, C., Ferrari, G., Verzeletti, S., Servida, P., Zappone, E., Ruggieri, L., Ponzoni, M., Rossini, S., Mavilio, F., Traversari, C., et al. (1997) · Science · doi:10.1126/science.276.5319.1719 · Cited by 1,161
Giralt, S., Estey, E., Albitar, M., van Besien, K., Rondón, G., Anderlini, P., O'Brien, S., Khouri, I., Gajewski, J., Mehra, R., et al. (1997) · Blood · doi:10.1182/blood.v89.12.4531 · Cited by 1,138
Woo, E. Y., Chu, C., Goletz, T. J., Schlienger, K., Yeh, H., Coukos, G., Rubin, S. C., Kaiser, L. R., & June, C. H. (2001) · PubMed · Cited by 1,108
Self-citationRosenberg, S. A., Yannelli, J. R., Yang, J. C., Topalian, S. L., Schwartzentruber, D. J., Weber, J. S., Parkinson, D. R., Seipp, C. A., Einhorn, J. H., & White, D. E. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.15.1159 · Cited by 1,019
Sutmuller, R. P. M., van Duivenvoorde, L. M., van Elsas, A., Schumacher, T. N. M., Wildenberg, M. E., Allison, J. P., Toes, R. E. M., Offringa, R., & Melief, C. J. M. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.823 · Cited by 1,008
Lamers, C. H. J., Sleijfer, S., Vulto, A. G., Kruit, W. H. J., Kliffen, M., Debets, R., Gratama, J. W., Stoter, G., & Oosterwijk, E. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.05.9964 · Cited by 915
Takayama, T., Sekine, T., Makuuchi, M., Yamasaki, S., Kosuge, T., Yamamoto, J., Shimada, K., Sakamoto, M., Hirohashi, S., Ohashi, Y., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02654-4 · Cited by 847
Control of Homeostasis of CD8 + Memory T Cells by Opposing Cytokines
Ku, C. C., Murakami, M., Sakamoto, A., Kappler, J., & Marrack, P. (2000) · Science · doi:10.1126/science.288.5466.675 · Cited by 816
Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-β signals in vivo
Chen, M.-L., Pittet, M. J., Gorelik, L., Flavell, R. A., Weissleder, R., von Boehmer, H., & Khazaie, K. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408197102 · Cited by 806
Serafini, P., Meckel, K., Kelso, M., Noonan, K., Califano, J., Koch, W., Dolcetti, L., Bronte, V., & Borrello, I. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061104 · Cited by 766
Mackinnon, S., Papadopoulos, E., Carabasi, M., Reich, L., Collins, N., Boulad, F., Castro-Malaspina, H., Childs, B., Gillio, A., & Kernan, N. (1995) · Blood · doi:10.1182/blood.v86.4.1261.bloodjournal8641261 · Cited by 722
Dudley, M. E., Wunderlich, J. R., Shelton, T. E., Even, J., & Rosenberg, S. A. (2003) · Journal of Immunotherapy · doi:10.1097/00002371-200307000-00005 · Cited by 701
Montini, E., Cesana, D., Schmidt, M., Sanvito, F., Ponzoni, M., Bartholomae, C., Sergi, L. S., Benedicenti, F., Ambrosi, A., Di Serio, C., et al. (2006) · Nature Biotechnology · doi:10.1038/nbt1216 · Cited by 701
Immunotherapy and chemotherapy — a practical partnership
Lake, R. A., & Robinson, B. W. S. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1613 · Cited by 646
Rosenberg, S. A., Lotze, M. T., Yang, J. C., Topalian, S. L., Chang, A. E., Schwartzentruber, D. J., Aebersold, P., Leitman, S., Linehan, W. M., Seipp, C. A., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.8.622 · Cited by 639
Greenberg, P. D. (1991) · Advances in Immunology · doi:10.1016/s0065-2776(08)60778-6 · Cited by 603
Park, J. R., DiGiusto, D. L., Slovak, M., Wright, C., Naranjo, A., Wagner, J., Meechoovet, H. B., Bautista, C., Chang, W.-C., Ostberg, J. R., et al. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300104 · Cited by 603
Focus on hepatocellular carcinoma
Bruix, J., Boix, L., Sala, M., & Llovet, J. M. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00058-3 · Cited by 570
Riddell, S. R., Elliott, M., Lewinsohn, D. A., Gilbert, M. J., Wilson, L., Manley, S. A., Lupton, S. D., Overell, R. W., Reynolds, T. C., Corey, L., et al. (1996) · Nature Medicine · doi:10.1038/nm0296-216 · Cited by 565
Redesigning an FKBP–ligand interface to generate chemical dimerizers with novel specificity
Clackson, T., Yang, W., Rozamus, L. W., Hatada, M., Amara, J. F., Rollins, C. T., Stevenson, L. F., Magari, S. R., Wood, S. A., Courage, N. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.18.10437 · Cited by 558
Concomitant Tumor Immunity to a Poorly Immunogenic Melanoma Is Prevented by Regulatory T Cells
Turk, M. J., Guevara-Patiño, J. A., Rizzuto, G. A., Engelhorn, M. E., & Houghton, A. N. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20041130 · Cited by 540
Targeting tumours with genetically enhanced T lymphocytes
Sadelain, M., Rivière, I., & Brentjens, R. (2003) · Nature Reviews Cancer · doi:10.1038/nrc971 · Cited by 535
Gene transfer in humans using a conditionally replicating lentiviral vector
Levine, B. L., Humeau, L. M., Boyer, J., MacGregor, R.-R., Rebello, T., Lu, X., Binder, G. K., Slepushkin, V., Lemiale, F., Mascola, J. R., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608138103 · Cited by 501
Self-citationLarge-scale in vitro expansion of polyclonal human CD4+CD25high regulatory T cells
Hoffmann, P., Eder, R., Kunz-Schughart, L. A., Andreesen, R., & Edinger, M. (2004) · Blood · doi:10.1182/blood-2004-01-0086 · Cited by 494
Klebanoff, C. A., Khong, H. T., Antony, P. A., Palmer, D. C., & Restifo, N. P. (2005) · Trends in Immunology · doi:10.1016/j.it.2004.12.003 · Cited by 469
Chakraborty, M., Abrams, S. I., Camphausen, K., Liu, K., Scott, T., Coleman, C. N., & Hodge, J. W. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.12.6338 · Cited by 467
Machiels, J.-P., Reilly, R. T., Emens, L. A., Ercolini, A. M., Lei, R. Y., Weintraub, D., Okoye, F. I., & Jaffee, E. M. (2001) · PubMed · Cited by 453
Melanocyte Destruction after Antigen-Specific Immunotherapy of Melanoma
Yee, C., Thompson, J. A., Roche, P., Byrd, D. R., Lee, P. P., Piepkorn, M., Kenyon, K., Davis, M. M., Riddell, S. R., & Greenberg, P. D. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.11.1637 · Cited by 428
Mitsuyasu, R. T., Anton, P. A., Deeks, S. G., Scadden, D. T., Connick, E., Downs, M. T., Bakker, A., Roberts, M. R., June, C. H., Jalali, S., et al. (2000) · Blood · doi:10.1182/blood.v96.3.785 · Cited by 425
Self-citationThe Makings of a Tumor Rejection Antigen
Gilboa, E. (1999) · Immunity · doi:10.1016/s1074-7613(00)80101-6 · Cited by 381
Silencing and Variegation of Gammaretrovirus and Lentivirus Vectors
Ellis, J. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.1241 · Cited by 379
Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cells
Zhang, H., Chua, K. S., Guimond, M., Kapoor, V., Brown, M. V., Fleisher, T. A., Long, L. M., Bernstein, D., Hill, B. J., Douek, D. C., et al. (2005) · Nature Medicine · doi:10.1038/nm1312 · Cited by 377
Kernan, N., Collins, N., Juliano, L., Cartagena, T., Dupont, B., & O'Reilly, R. (1986) · Blood · doi:10.1182/blood.v68.3.770.770 · Cited by 365
Induced sensitization of tumor stroma leads to eradication of established cancer by T cells
Zhang, B., Bowerman, N. A., Salama, J. K., Schmidt, H., Spiotto, M. T., Schietinger, A., Yu, P., Fu, Y.-X., Weichselbaum, R. R., Rowley, D. A., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062056 · Cited by 359
Eradication of Established Tumors by CD8+ T Cell Adoptive Immunotherapy
Hanson, H. L., Donermeyer, D. L., Ikeda, H., White, J. M., Shankaran, V., Old, L. J., Shiku, H., Schreiber, R. D., & Allen, P. M. (2000) · Immunity · doi:10.1016/s1074-7613(00)00026-1 · Cited by 358
(2003) · PubMed · Cited by 357
Levine, B. L., Bernstein, W. B., Connors, M., Craighead, N., Lindsten, T., Thompson, C. B., & June, C. H. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.12.5921 · Cited by 340
Self-citationBerger, C., Flowers, M. E., Warren, E. H., & Riddell, S. R. (2006) · Blood · doi:10.1182/blood-2005-08-3503 · Cited by 334
STUDIES ON THE IMMUNOLOGICAL RESPONSE TO FOREIGN TUMOR TRANSPLANTS IN THE MOUSE
Mitchison, N. A. (1955) · The Journal of Experimental Medicine · doi:10.1084/jem.102.2.157 · Cited by 326
Hypothyroidism after Treatment with Interleukin-2 and Lymphokine-Activated Killer Cells
Atkins, M. B., Mier, J. W., Parkinson, D. R., Gould, J. A., Berkman, E. M., & Kaplan, M. M. (1988) · New England Journal of Medicine · doi:10.1056/nejm198806163182401 · Cited by 318
The CD28 family: a T-cell rheostat for therapeutic control of T-cell activation
Riley, J. L., & June, C. H. (2005) · Blood · doi:10.1182/blood-2004-04-1596 · Cited by 315
Self-citationWorkshop R: Tumor Immunology, Abstract R1 bis R30
(2001) · Immunobiology · doi:10.1016/s0171-2985(04)70018-2 · Cited by 312
Kershaw, M. H., Wang, G., Westwood, J. A., Pachynski, R. K., Tiffany, H. L., Marincola, F. M., Wang, E., Young, H. A., Murphy, P. M., & Hwu, P. (2002) · Human Gene Therapy · doi:10.1089/10430340260355374 · Cited by 297
Mackensen, A., Meidenbauer, N., Vogl, S., Laumer, M., Berger, J., & Andreesen, R. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.1100 · Cited by 297
Rapoport, A. P., Stadtmauer, E. A., Aqui, N., Badros, A., Cotte, J., Chrisley, L., Veloso, E., Zheng, Z., Westphal, S., Mair, R., et al. (2005) · Nature Medicine · doi:10.1038/nm1310 · Cited by 290
Self-citationGodfrey, W. R., Ge, Y. G., Spoden, D. J., Levine, B. L., June, C. H., Blazar, B. R., & Porter, S. B. (2004) · Blood · doi:10.1182/blood-2004-01-0151 · Cited by 277
Self-citationSchumacher, T. N. M. (2002) · Nature Reviews Immunology · doi:10.1038/nri841 · Cited by 274
Cheever, M. A., Greenberg, P. D., Fefer, A., & Gillis, S. (1982) · The Journal of experimental medicine · doi:10.1084/jem.155.4.968 · Cited by 265
Principles of adoptive T cell cancer therapy
June, C. H. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31446 · Cited by 261
Self-citationIrvine, K. R., Rao, J. B., Rosenberg, S. A., & Restifo, N. P. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.1.238 · Cited by 233
Yoshizawa, H., Chang, A. E., & Shu, S. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.2.729 · Cited by 212
Figlin, R. A., Thompson, J. A., Bukowski, R. M., Vogelzang, N. J., Novick, A. C., Lange, P., Steinberg, G. D., & Belldegrun, A. S. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.8.2521 · Cited by 212
Adoptive cellular immunotherapy for EBV lymphoproliferative diseases
Heslop, H. E., & Rooney, C. M. (1997) · Immunological Reviews · doi:10.1111/j.1600-065x.1997.tb00984.x · Cited by 205
Wrzesinski, C., Paulos, C. M., Gattinoni, L., Palmer, D. C., Kaiser, A., Yu, Z., Rosenberg, S. A., & Restifo, N. P. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30414 · Cited by 202
Loskog, A., Giandomenico, V, Rossig, C., Pule, M., Dotti, G., & Brenner, M. K. (2006) · Leukemia · doi:10.1038/sj.leu.2404366 · Cited by 192
Inducing autoimmune disease to treat cancer
Pardoll, D. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5340 · Cited by 183
Rufer, N., Migliaccio, M., Antonchuk, J., Humphries, R. K., Roosnek, E., & Lansdorp, P. M. (2001) · Blood · doi:10.1182/blood.v98.3.597 · Cited by 180
Laport, G. G., Levine, B. L., Stadtmauer, E. A., Schuster, S. J., Luger, S. M., Grupp, S., Bunin, N., Strobl, F. J., Cotte, J., Zheng, Z., et al. (2003) · Blood · doi:10.1182/blood-2003-01-0095 · Cited by 179
Self-citationO'Reilly, R. J., Small, T. N., Papadopoulos, E., Lucas, K., Lacerda, J., & Koulova, L. (1997) · Immunological Reviews · doi:10.1111/j.1600-065x.1997.tb00983.x · Cited by 175
Levine, B. L., Bernstein, W. B., Aronson, N. E., Schlienger, K., Cotte, J., Perfetto, S., Humphries, M. J., Ratto-Kim, S., Birx, D. L., Steffens, C., et al. (2002) · Nature Medicine · doi:10.1038/nm0102-47 · Cited by 170
Self-citationAntitumor effects of HSV-TK–engineered donor lymphocytes after allogeneic stem-cell transplantation
Ciceri, F., Bonini, C., Marktel, S., Zappone, E., Servida, P., Bernardi, M., Pescarollo, A., Bondanza, A., Peccatori, J., Rossini, S., et al. (2007) · Blood · doi:10.1182/blood-2006-05-023416 · Cited by 170
Chang, A. E., Aruga, A., Cameron, M. J., Sondak, V. K., Normolle, D. P., Fox, B. A., & Shu, S. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.2.796 · Cited by 165
Functional expression of chimeric receptor genes in human T cells
Eshhar, Z., Waks, T., Bendavid, A., & Schindler, D. G. (2001) · Journal of Immunological Methods · doi:10.1016/s0022-1759(00)00343-4 · Cited by 158
Adoptive immunotherapy: Engineering T cell responses as biologic weapons for tumor mass destruction
Ho, W., Blattman, J. N., Dossett, M. L., Yee, C., & Greenberg, P. D. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00113-2 · Cited by 157
Topp, M. S., Riddell, S. R., Akatsuka, Y., Jensen, M. C., Blattman, J. N., & Greenberg, P. D. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021288 · Cited by 144
Cancer immunotherapy: breaking the barriers to harvest the crop
Pardoll, D. M., & Allison, J. P. (2004) · Nature Medicine · doi:10.1038/nm0904-887 · Cited by 135
Dréno, B., Nguyen, J., Khammari, A., Pandolfino, M. C., Tessier, M., Bercegeay, S., Cassidanius, A., Lemarre, P., Billaudel, S., Labarrière, N., et al. (2002) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-002-0315-1 · Cited by 122
Ratto, G. B., Zino, P., Mirabelli, S., Minuti, P., Aquilina, R., Fantino, G., Spessa, E., Ponte, M., Bruzzi, P., & Melioli, G. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960715)78:2<244::aid-cncr9>3.0.co;2-l · Cited by 121
Divergent Roles for CD4+ T Cells in the Priming and Effector/Memory Phases of Adoptive Immunotherapy
Hu, H., Winter, H., Urba, W. J., & Fox, B. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.8.4246 · Cited by 117
Kono, K., Takahashi, A., Ichihara, F., Amemiya, H., Iizuka, H., Fujii, H., Sekikawa, T., & Matsumoto, Y. (2002) · PubMed · Cited by 112
Vignard, V., Lemercier, B., Lim, A., Pandolfino, M., Guilloux, Y., Khammari, A., Rabu, C., Echasserieau, K., Lang, F., Gougeon, M., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.7.4797 · Cited by 104
Effect of leukocytes on transplantability of human cancer
Southam, C. M., Brunschwig, A., LEVIN, A. G., & Dizon, Q. S. (1966) · Cancer · doi:10.1002/1097-0142(196611)19:11<1743::aid-cncr2820191143>3.0.co;2-u · Cited by 102
Towards patient‐specific tumor antigen selection for vaccination
Rammensee, H., Weinschenk, T., Gouttefangeas, C., & Eq, S. S. (2002) · Immunological Reviews · doi:10.1034/j.1600-065x.2002.18815.x · Cited by 84
Wang, L., Li, R. Q., Yang, G., Lim, M., O’Hara, A. C., Chu, Y., Fox, B. A., Restifo, N. P., Urba, W. J., & Hu, H. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2117 · Cited by 83
Sabel, M. S., Arora, A., Su, G., & Chang, A. E. (2006) · Cryobiology · doi:10.1016/j.cryobiol.2006.07.004 · Cited by 81
Grabert, R. C., Cousens, L. P., Smith, J. A., Olson, S., Gall, J., Young, W. B., Davol, P. A., & Lum, L. G. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2005 · Cited by 79
Wang, L.-X., Shu, S., & Plautz, G. E. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1175 · Cited by 74
Norell, H., Carlsten, M., Ohlum, T., Malmberg, K., Masucci, G. V., Schedvins, K., Altermann, W., Handke, D., Atkins, D., Seliger, B., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0029 · Cited by 66
Suzuki, E., Kapoor, V., Cheung, H.-K., Ling, L. E., DeLong, P. A., Kaiser, L. R., & Albelda, S. M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0611 · Cited by 65
Tuttle, T. M., Inge, T. H., Bethke, K. P., McCrady, C. W., Pettit, G. R., & Bear, H. D. (1992) · PubMed · Cited by 56
Tumor antigen immunization of sibling stem cell transplant donors in multiple myeloma
Neelapu, S. S., Munshi, N. C., Jagannath, S., Watson, T. M., Pennington, R. M., Reynolds, C. G., Barlogie, B., & Kwak, L. W. (2005) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1705057 · Cited by 56
Mauri, D., Wyss‐Coray, T., Gallati, H., & Pichler, W. J. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.1.118 · Cited by 55
Curti, B. D., Ochoa, A. C., Powers, G. C., Kopp, W. C., Alvord, W. G., Janik, J. E., Gause, B. L., Dunn, B., KOPRESKI, M. S., Fenton, R., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.8.2752 · Cited by 55
Peng, L., Kjærgaard, J., Plautz, G. E., Awad, M., Drazba, J. A., Shu, S., & Cohen, P. A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.9.4811 · Cited by 51
Teshima, T., Liu, C., Lowler, K. P., Dranoff, G., & Ferrara, J. L. M. (2002) · PubMed · Cited by 36
Renner, C., Bauer, S., Şahin, U., Jung, W. E., van Lier, R. A. W., Jacobs, G., Held, G., & Pfreundschuh, M. G. (1996) · Blood · doi:10.1182/blood.v87.7.2930.bloodjournal8772930 · Cited by 34
Graham, S. D., Babayan, R. K., Dl, L., Sawczuk, I. S., Ross, S. D., Lavin, P. T., Osband, M. E., & Krane, R. J. (1993) · PubMed · Cited by 32
Parviz, M., Chin, C. S., Graham, L., Miller, C. H. T., Lee, C., George, K. R., & Bear, H. D. (2003) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-003-0405-8 · Cited by 29
De, A. K., Miller‐Graziano, C. L., Calvano, S. E., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.9.6155 · Cited by 27
Evans, L. S., Witte, P., Feldhaus, A. L., Nelson, B. H., Riddell, S., Greenberg, P. D., Lupton, S. D., & Jones, L. A. (1999) · Human Gene Therapy · doi:10.1089/10430349950017301 · Cited by 26
Ratto, G. B., Cafferata, M. A., Scolaro, T., et al. (2000) · Journal of Immunotherapy · doi:10.1097/00002371-200001000-00019 · Cited by 17
To ablate or not to ablate? HSCs in the T cell driver’s seat
Anasetti, C., & Mulé, J. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30973 · Cited by 14
Cited by
Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
Bindea, G., Mlecnik, B., Tosolini, M., Kirilovsky, A., Waldner, M., Obenauf, A. C., Angell, H., Fredriksen, T., Lafontaine, L., Berger, A., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.10.003 · Cited by 4,422
A human memory T cell subset with stem cell–like properties
Gattinoni, L., Lugli, E., Ji, Y., Pos, Z., Paulos, C. M., Quigley, M. F., Almeida, J. R., Gostick, E., Yu, Z., Carpenito, C., et al. (2011) · Nature Medicine · doi:10.1038/nm.2446 · Cited by 1,974
Self-citationImmune evasion in cancer: mechanistic basis and therapeutic strategies
Vinay, D. S., Ryan, E. P., Pawelec, G., Talib, W. H., Stagg, J., Elkord, E., Lichtor, T., Decker, W. K., Whelan, R. L., Kumara, H. M. C. S., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.03.004 · Cited by 1,625
Mlecnik, B., Tosolini, M., Kirilovsky, A., Berger, A., Bindea, G., Meatchi, T., Bruneval, P., Trajanoski, Z., Fridman, W.-H., Pagès, F., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.5425 · Cited by 1,009
Quezada, S. A., Simpson, T. R., Peggs, K. S., Merghoub, T., Vider, J., Fan, X., Blasberg, R., Yagita, H., Muranski, P., Antony, P. A., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20091918 · Cited by 898
Metadata
- Authors
- June, C. H.
- Venue
- Journal of Clinical Investigation
- Published
- 2007-06-01
- Volume
- 117
- Issue
- 6
- Pages
- 1466-1476
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2141262236
- Cited by
- 553
- References
- 112
- FWCI
- 17.66
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.